Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3288293rdf:typepubmed:Citationlld:pubmed
pubmed-article:3288293lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3288293lifeskim:mentionsumls-concept:C0021246lld:lifeskim
pubmed-article:3288293lifeskim:mentionsumls-concept:C0035435lld:lifeskim
pubmed-article:3288293lifeskim:mentionsumls-concept:C0033923lld:lifeskim
pubmed-article:3288293lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3288293pubmed:issue3lld:pubmed
pubmed-article:3288293pubmed:dateCreated1988-7-28lld:pubmed
pubmed-article:3288293pubmed:abstractTextWe have compared the effect of single and multiple doses of indomethacin and placebo on objective measurements of psychomotor impairment in patients. Following a single 50 mg dose (n = 8), indomethacin produced psychomotor disturbance in only those patients who had no recent history of NSAID exposure. After multiple doses of indomethacin (25 and 50 mg tid for 5 days), significant psychomotor impairment was observed. We conclude that other NSAIDs may induce cross-tolerance to the psychomotor effects of indomethacin. Tachyphylaxis may develop to the psychomotor disturbance caused by indomethacin.lld:pubmed
pubmed-article:3288293pubmed:languageenglld:pubmed
pubmed-article:3288293pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288293pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3288293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288293pubmed:statusMEDLINElld:pubmed
pubmed-article:3288293pubmed:monthJunlld:pubmed
pubmed-article:3288293pubmed:issn0263-7103lld:pubmed
pubmed-article:3288293pubmed:authorpubmed-author:NodaSSlld:pubmed
pubmed-article:3288293pubmed:authorpubmed-author:DixonJ SJSlld:pubmed
pubmed-article:3288293pubmed:authorpubmed-author:BirdH AHAlld:pubmed
pubmed-article:3288293pubmed:authorpubmed-author:PullarTTlld:pubmed
pubmed-article:3288293pubmed:authorpubmed-author:HaighJ RJRlld:pubmed
pubmed-article:3288293pubmed:authorpubmed-author:MyallOOlld:pubmed
pubmed-article:3288293pubmed:issnTypePrintlld:pubmed
pubmed-article:3288293pubmed:volume27lld:pubmed
pubmed-article:3288293pubmed:ownerNLMlld:pubmed
pubmed-article:3288293pubmed:authorsCompleteYlld:pubmed
pubmed-article:3288293pubmed:pagination227-9lld:pubmed
pubmed-article:3288293pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3288293pubmed:meshHeadingpubmed-meshheading:3288293-...lld:pubmed
pubmed-article:3288293pubmed:meshHeadingpubmed-meshheading:3288293-...lld:pubmed
pubmed-article:3288293pubmed:meshHeadingpubmed-meshheading:3288293-...lld:pubmed
pubmed-article:3288293pubmed:meshHeadingpubmed-meshheading:3288293-...lld:pubmed
pubmed-article:3288293pubmed:meshHeadingpubmed-meshheading:3288293-...lld:pubmed
pubmed-article:3288293pubmed:meshHeadingpubmed-meshheading:3288293-...lld:pubmed
pubmed-article:3288293pubmed:meshHeadingpubmed-meshheading:3288293-...lld:pubmed
pubmed-article:3288293pubmed:meshHeadingpubmed-meshheading:3288293-...lld:pubmed
pubmed-article:3288293pubmed:year1988lld:pubmed
pubmed-article:3288293pubmed:articleTitleThe effect of indomethacin on the psychomotor function of patients with rheumatic diseases.lld:pubmed
pubmed-article:3288293pubmed:affiliationDepartment of Medicine, University of Leeds, UK.lld:pubmed
pubmed-article:3288293pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3288293pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3288293pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3288293pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:3288293pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3288293lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3288293lld:pubmed